---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-013244"
form_type: "8-K"
ticker: "PMN"
cik: "0001374339"
company_name: "ProMIS Neurosciences Inc."
filed_at: "2024-10-10T23:59:59+00:00"
generated_at: "2026-05-30T16:28:53.289559+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Neil Warma appointed President and CEO of ProMIS Neurosciences, effective August 1, 2024

## Summary
- Base salary of $500,000 with annual discretionary bonus target of 50% of base salary.
- Granted option to purchase 1,144,122 common shares (Initial Award) and 490,338 shares (Performance Award) at $1.15 per share.
- Initial Award vests 25% on grant, remainder ratably over 36 months; Performance Award vests 25% when 10-day VWAP exceeds 3x exercise price, remainder over 36 months.
- Severance: 12 months' salary plus pro-rated bonus and time-based option acceleration on non-CIC termination; 18 months' salary plus benefits on change-in-control termination.

## SEC filing metadata
- accession: 0001558370-24-013244
- form_type: 8-K
- ticker: PMN
- cik: 0001374339
- company_name: ProMIS Neurosciences Inc.
- filed_at: 2024-10-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/0001558370-24-013244-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/pmn-20241008x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-013244
- JSON: https://secwatch.observer/filing/0001558370-24-013244.json
- Plain text: https://secwatch.observer/filing/0001558370-24-013244.txt

## Key facts
- Executive change
  Neil Warma was appointed as President and Chief Executive Officer at ProMIS Neurosciences Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On October 8, 2024, ProMIS Neurosciences Inc. (the “Company”) appointed Neil Warma as the President and Chief Executive Officer (“CEO”) of the Company, effective August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/0001558370-24-013244-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.